Staff Profile
Emeritus Professor Margaret Bassendine
Emeritus Professor
Publications
- Bridge SH, Pagano S, Jones M, Foster GR, Neely D, Vuilleumier N, Bassendine MF. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?. Hepatology International 2018, 12(1), 17-25.
- Bassendine MF, Nielsen SU, Bridge SH, Felmlee DJ, Sheridan DA, Packard CJ, Neely RD. Hepatitis C virus and atherosclerosis: A legacy after virologic cure?. Clinics and Research in Hepatology and Gastroenterology 2017, 41(1), 25-30.
- Sheridan DA, Hajarizadeh B, Fenwick FI, Matthews GV, Applegate T, Douglas M, Neely D, Askew B, Dore GJ, Lloyd AR, George J, Bassendine MF, Grebely J. Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection. Liver International 2016, 36(12), 1774-1782.
- Thabet K, Asimakopoulos A, Shojaei M, Romero-Gomez M, Mangia A, Irving WL, Berg T, Dore GJ, Gronbaek H, Sheridan D, Abate ML, Bugianesi E, Weltman M, Mollison L, Cheng W, Riordan S, Fischer J, Spengler U, Nattermann J, Wahid A, Rojas A, White R, Douglas MW, McLeod D, Powell E, Liddle C, Van Der Poorten D, George J, Eslam M, Gallego-Duran R, Applegate T, Bassendine M, Rosso C, Mezzabotta L, Leung R, Malik B, Matthews G, Grebely J, Fragomeli V, Jonsson JR, Santaro R. MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. Nature Communications 2016, 7, 12757.
- Sheridan DA, Romero MG, Bridge S, Crossey M, Shawa IT, Neely D, Felmlee D, Holmes E, Bassendine M, Taylor-Robinson S. Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection. In: International Liver Congress 2015 - 50th Annual meeting of the European Association for the Study of the Liver. 2015, Vienna, Austria: Elsevier.
- Sheridan DA, Bridge SH, Crossey MME, Felmlee DJ, Thomas HC, Neely RDG, Taylor-Robinson SD, Bassendine MF. Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency. Metabolic Brain Disease 2014, 29(3), 625-634.
- Sheridan DA, Hajarizadeh B, Matthews G, Applegate TL, Douglas MW, Askew B, Neely D, Bassendine MF, Dore GJ, Lloyd AR, George J, Grebely J. Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection. In: 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2014. 2014, Boston, MA: John Wiley & Sons, Inc.
- Sheridan DA, Bridge SH, Crossey MME, Felmlee DJ, Fenwick FI, Thomas HC, Neely RDG, Taylor-Robinson SD, Bassendine MF. Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial. Liver International 2014, 34(5), 737-747.
- Smith KR, Suppiah V, O'Connor K, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Matthews G, Irving WL, Powell E, Riordan S, Ahlenstiel G, Stewart GJ, Bahlo M, George J, Booth DR, the International Hepatitis C Genetics Consortium (IHCGC). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine 2011, 3, 57.